Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Smither John W
Relationship:   Director
City:   Calabasas
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   89,084    

Indirect Shares

   176,353      
Direct Value   $122,234    

Indirect Value

   $1,295,151      
Total Shares   265,437      
Total Value   $1,417,385      


Sienna Biopharmaceuticals, Inc. $0 Arcutis Biotherapeutics, Inc. $104,103 Effector Therapeutics Ord Shs $0 Genelux Corp $18,130 Sienna Biopharmaceuticals, Inc. $0 Arcutis Biotherapeutics, Inc. $104,103 Effector Therapeutics Ord Shs $0 Genelux Corp $18,130
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -78.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Kythera Biopharmaceuticals Inc KYTH Chief Financial Officer 2015-10-01 0 2015-10-01 0    Premium*  
            Sienna Biopharmaceuticals, Inc. SNNA 2019-01-01 46,657 2019-01-01 34,961    Premium*  
            Arcutis Biotherapeutics, Inc. ARQT Chief Financial Officer 2024-02-13 11,365 2024-02-13 141,392    Premium*  
            Effector Therapeutics Ord Shs EFTR Director 2021-08-25 24,142 2021-08-25 0    Premium*  
            Genelux Corp GNLX Director 2023-09-13 6,920 2023-09-11 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-06-25 4 S $75.50 $347,300 D/D (4,600) 10,984 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-06-25 4/A S $75.50 $347,300 I/I (4,600) 7,616 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-09-18 4 S $74.95 $78,997 D/D (1,054) 3,368 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-09-22 4 S $74.90 $418,766 D/D (5,591) 3,368 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-09-23 4 S $74.90 $2,016,158 D/D (26,918) 3,368 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-09-24 4 S $74.90 $2,016,083 D/D (26,917) 3,368 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-02-14 4 AS $50.00 $56,250 D/D (1,125) 10,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-02-20 4 AS $49.75 $111,926 D/D (2,250) 10,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-03-05 4 AS $46.99 $201,980 I/I (4,200) 12,216 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-04-30 4/A S $45.49 $92,845 D/D (2,041) 3,368 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-04-30 4 S $45.49 $92,845 D/D (2,041) 15,584 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-03-20 4 AS $43.78 $49,253 D/D (1,125) 10,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-01-21 4 AS $42.54 $47,856 D/D (1,125) 10,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-02-18 4 AS $42.00 $42,000 I/I (1,000) 16,416 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-07-02 4 AS $40.00 $90,000 D/D (2,250) 16,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-02-17 4 AS $40.00 $40,000 I/I (1,000) 17,416 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-06-20 4 AS $38.06 $14,273 D/D (375) 16,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-01-29 4 AS $38.00 $38,000 I/I (1,000) 18,416 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-04-21 4 AS $36.12 $13,545 D/D (375) 13,200 0 -
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2021-02-10 4 AS $35.64 $71,280 I/I (2,000) 87,965 0 %
ARQT Arcutis Biotherapeutics, ... Chief Financial Officer   •       –      –    2021-02-10 4 AS $35.64 $26,730 D/D (750) 25,198 0 %
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-09-22 4 AS $35.61 $13,354 D/D (375) 16,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-12-22 4 AS $35.49 $13,309 D/D (375) 16,200 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2015-01-23 4 AS $35.47 $106,940 I/I (3,000) 19,416 0 -
KYTH Kythera Biopharmaceutical... Chief Financial Officer   •       –      –    2014-08-20 4 AS $35.04 $13,140 D/D (375) 16,200 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us